Capital Flow Monitor · Sponsors · CIK 1801323
PLEOPHARMA, INC.
518 KIMBERTON RD., PHOENIXVILLE, PA, 19460 · (610) 937-2882
Pharmaceuticals · Corporation· inc. DELAWARE true
Fit score
—
Offering
$36.2M
Sold
$6.2M
% sold
17.0%
Investors
9
Min investment
$50K
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2026-08-10 | D | 506(b) | $15.0M | $5.5M | 36.7% | 11 | EDGAR ↗ |
| 2025-08-08 | D ·current | 506(b) | $36.2M | $6.2M | 17.0% | 9 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
- Ginger Constantine — Executive Officer / Director, Phoenixville, PA 19460, PA
- Jay Constantine — Executive Officer / Director, Phoenixville, PA 19460, PA
- Robert Finizio — Director, Phoenixville, PA 19460, PA
- Bisaro Paul — Director, Phoenixville, PA 19460, PA
- Thompson Tommy — Director, Phoenixville, PA 19460, PA
-
Sarah Hassan — Director, Phoenixville, PA 19460, PA
1 other raise
- Vinci Pharmaceuticals, Inc. $20.2M of $25.3M · 79.8%
-
Brij Sharma — Director, Phoenixville, PA 19460, PA
1 other raise
- NTV Healthcare Innovation Fund, LP $20.0M of $100.0M · 20.0%
- Daniel Alan Cartwright — Executive Officer, Phoenixville, PA 19460, PA
- Thomas F Poche — Executive Officer, Phoenixville, PA 19460, PA
- Timothy McInerney — Director, Phoenixville, PA
Placement agents
- Castle Hill Capital Partners, Inc. · 0 RE raises
- Supervision Partners Llc · 0 RE raises
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.